HLA-B57:01

The study carried out in patients taking antiretroviral pharmacological preparation of abacavir to prevent the allergic reactions. It is recommended to all persons infected with human immunodeficiency virus (HIV), prior to the administration of pharmaceuticals containing an abacavir sulfate.

More information: www.euroimmun.com